The Data Behind the FDA's Zantac Recall

On April 1, 2020, the US FDA recalled the popular heart burn medication Zantac, and its generic Ranitidine. Having reported on the concern surrounding Zantac back in November, we continue to provide consumers the latest on the data behind the FDA's decision, as well as the cancers that are believed to be linked to the popular medication.